Soleno Therapeutics, Inc.
SLNO
$33.39
-$0.37-1.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 66.68% | 652.53% | 89.24% | 21.81% | 26.93% |
| Total Depreciation and Amortization | 1.39% | 0.00% | -0.40% | 0.20% | 0.60% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 12.50% | -- | -- |
| Total Other Non-Cash Items | 8.37% | 3.69% | -40.67% | -41.60% | -48.13% |
| Change in Net Operating Assets | -197.86% | 135.59% | -189.76% | -343.62% | -52.68% |
| Cash from Operations | 12.08% | 444.65% | 61.50% | -36.52% | -60.73% |
| Capital Expenditure | -5,700.00% | 88.89% | -80.00% | 37.50% | 95.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -37.03% | -1,056.62% | -134.46% | 255.63% | 52.47% |
| Cash from Investing | -37.09% | -1,055.31% | -134.51% | 256.00% | 59.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.56% | 1,270.92% | 384.76% | -54.29% | 215.38% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 200.00% | -187.10% | -- | -- |
| Cash from Financing | -145.79% | 1,290.49% | 387.54% | -94.36% | 2,408.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -203.76% | 3,620.17% | 26.72% | -116.69% | 558.89% |